000 01750 a2200517 4500
005 20250514003400.0
264 0 _c20010816
008 200108s 0 0 eng d
022 _a0969-9961
024 7 _a10.1006/nbdi.2001.0393
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCallizot, N
245 0 0 _aThe frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome.
_h[electronic resource]
260 _bNeurobiology of disease
_cJun 2001
300 _a447-58 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntiparkinson Agents
_xpharmacology
650 0 4 _aApomorphine
_xpharmacology
650 0 4 _aBehavior, Animal
_xdrug effects
650 0 4 _aCorpus Striatum
_xcytology
650 0 4 _aDisease Models, Animal
650 0 4 _aElectromyography
650 0 4 _aFemale
650 0 4 _aGenes, Recessive
650 0 4 _aImmunohistochemistry
650 0 4 _aIndoles
_xpharmacology
650 0 4 _aLevodopa
_xpharmacology
650 0 4 _aMale
650 0 4 _aMemory Disorders
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, Inbred C3H
650 0 4 _aMice, Neurologic Mutants
650 0 4 _aMotor Activity
_xdrug effects
650 0 4 _aNeurons
_xenzymology
650 0 4 _aParkinson Disease, Secondary
_xdrug therapy
650 0 4 _aPostural Balance
_xdrug effects
650 0 4 _aSelegiline
_xpharmacology
650 0 4 _aTyrosine 3-Monooxygenase
_xanalysis
700 1 _aGuénet, J L
700 1 _aBaillet, C
700 1 _aWarter, J M
700 1 _aPoindron, P
773 0 _tNeurobiology of disease
_gvol. 8
_gno. 3
_gp. 447-58
856 4 0 _uhttps://doi.org/10.1006/nbdi.2001.0393
_zAvailable from publisher's website
999 _c11371194
_d11371194